In Vivo Antimalarial Activities of Mono- and Bis Quaternary Ammonium Salts Interfering with Plasmodium Phospholipid Metabolism
Open Access
- 1 August 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (8), 2598-2605
- https://doi.org/10.1128/aac.47.8.2598-2605.2003
Abstract
We previously showed that quaternary ammonium salts have potent antimalarial activities against the blood stage of drug-resistant Plasmodium falciparum . In the present study, 13 compounds of this series were comparatively assessed in murine in vivo malarial models. Mice infected with Plasmodium berghei were successfully treated with 11 quaternary ammonium salts in a 4-day suppressive test with a once-daily intraperitoneal administration. The dose required to decrease parasitemia by 50% (ED 50 ) ranged from 0.04 to 4.5 mg/kg of body weight. For six mono- and three bis-quaternary ammonium salts, the therapeutic indices (i.e., 50% lethal dose and ED 50 ) were higher than 5, and at best, around 20 to 30 for five of them (E6, E8, F4, G5, and G25), which is comparable to that of chloroquine under the same conditions. Plasmodium chabaudi was significantly more susceptible to G5, G15, and G25 compounds than P. berghei . Similar therapeutic indices were obtained, regardless of the administration mode or initial parasitemia (up to 11.2%). Parasitemia clearance was complete without recrudescence. Subcutaneously administered radioactive compounds had a short elimination half-life in mice (3.5 h) with low bioavailability (17.3%), which was likely due to the permanent cationic charge of the molecule. The high in vivo therapeutic index in the P. chabaudi -infected mouse model and the absence of recrudescence highlight the enormous potential of these quaternary ammonium salts for clinical malarial treatment.Keywords
This publication has 30 references indexed in Scilit:
- Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial ActivitiesAntimicrobial Agents and Chemotherapy, 2003
- A Class of Potent Antimalarials and Their Specific Accumulation in Infected ErythrocytesScience, 2002
- Medical need, scientific opportunity and the drive for antimalarial drugsNature, 2002
- Pharmacokinetics of Artemisinin-Type CompoundsClinical Pharmacokinetics, 2000
- Antimalarial Activity of Molecules Interfering with Plasmodium falciparum Phospholipid Metabolism. Structure−Activity Relationship AnalysisJournal of Medicinal Chemistry, 1997
- The chemosensitivity of the rodent malarias — relationships with the biology of merozoiteInternational Journal for Parasitology, 1994
- Plasmodium berghei: The antimalarial action of artemisinin and sodium artelinate in vivo and in vitro, studied by flow cytometryExperimental Parasitology, 1990
- Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Protoberberine alkaloids as antimalarialsJournal of Medicinal Chemistry, 1988
- Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transportAntimicrobial Agents and Chemotherapy, 1986